Cat.#: ACPP-1547
| Despition | CA14 Human Recombinant |
| SIZE | 5 µg |
| Purity | > 85.0% (SDS-PAGE) |
| Form | Sterile Filtered colorless solution. |
| Storage | Lyophilized was stored at -20°C to -80°C, while reconstituted was aliquot and stored at -80°C. Avoid freeze/thaw cycles. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1251 | EAAT2 Blocking Peptide (AC1251) | 250 µg | inquiry |
| ACPP-1163 | Recombinant Human GFAP Protein (Fc Tag) (AC1163) | 50 µg | inquiry |
| ACPP-1066 | Recombinant Human FGF2 Protein (Fc Tag) (AC1066) | 50 µg | inquiry |
| ACPP-1530 | Mouse METRN Protein (AC1530) | 1 µg | inquiry |
| ACPP-1378 | Human EFNB3 Protein (AC1378) | 5 µg | inquiry |
| ACPP-1775 | Human SNPH Protein (AC1775) | 10 µg | inquiry |
| ACPP-1591 | Mouse VCAM1 Protein (AC1591) | 2 µg | inquiry |
| ACPP-1779 | Human HSD17B10 Protein (AC1779) | 5 µg | inquiry |
| ACPP-1167 | Recombinant Human CD133 Protein (Fc Tag) (AC1167) | 50 µg | inquiry |
| ACPP-1750 | Human LCN1 Protein (AC1750) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.